Transjugular intrahepatic portosystemic stent shunt (TIPSS) is a new non-operative treatment of portal hypertension. The technique is based on the transjugular introduction of an expandable vascular stent which is implanted into the liver parenchyma between a main branch of the portal vein and a hepatic vein. Twelve patients with liver cirrhosis and recurrent variceal hemorrhage, who were excluded from operative treatment, were included in a pilot study. All patients either refused surgery or were considered poor surgical candidates. TIPSS was successfully established in 9 of the patients (75%). 58% of the patients survived 12 months and 50% 24 months. Variceal rebleeding occurred in 1 patient. Aggravation of hepatic encephalopathy was found in 1 patient. The results of this pilot study indicate that TIPSS controls variceal bleedings effectively during a follow-up of up to 2 years. It may be suitable for patients with advanced liver disease and high operative risk. It also does not limit later consideration for liver transplantation. During the course of the study, refinements of the technique have led to an even safer procedure which generally can be completed in 1 -2 h.

Keywords:
Stent shunt, transjugular intrahepatic portosystemic, Hypertension, portal, Cirrhosis, Hemorrhage, variceal
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.